ADRIAN CARTER, D.O.

Emergency department visit with high level of medical decision making

Emergency department visit with moderate level of medical decision making

Biopsy of related skin growth, first growth

Pneumococcal vaccine, 13-valent

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus

Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit

Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes

Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

Established patient office or other outpatient visit, 30-39 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes

Established patient office or other outpatient visit, 20-29 minutes

Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage

Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older)

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only

Adm sarscv2 bvl 30mcg/.3ml a

Injection of drug or substance under skin or into muscle

Smoking and tobacco use intensive counseling, 4-10 minutes

Administration of influenza virus vaccine

Administration of vaccine

Administration of pneumococcal vaccine

Injection, triamcinolone acetonide, not otherwise specified, 10 mg

Automated urinalysis test

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Injection, dexamethasone sodium phosphate, 1 mg